Company Filing History:
2 out of 453 
1 out of 1 
1 out of 3 Years Active: 2015-2022
Title: The Innovative Contributions of Lina Badimon Maestro in Ischemia Research
Introduction
Lina Badimon Maestro is a prominent inventor based in Barcelona, Spain, known for her significant contributions to the field of ischemia research. With three patented innovations to her name, she has made remarkable strides in diagnosing and treating ischemic conditions, which affect countless patients worldwide.
Latest Patents
Lina's latest patents focus on advanced methods and kits for diagnosing ischemia and risk stratification in patients. Her first invention pertains to methods for diagnosing ischemic tissue damage, predicting its progression after an ischemic event, and determining the risk of recurrent events in patients with stable coronary disease through the detection of glycosylated Apo J levels. Additionally, she has developed a method for determining glycosylated Apo J in samples, which is crucial for patient care.
The second patent is aimed at the prevention and treatment of ischemia or ischemia/reperfusion injury. This innovation encompasses pharmaceutical compositions that include various compounds, such as polypeptides and polynucleotides, designed to tackle ischemic injuries effectively. The versatility of these compounds is showcased in their potential uses for treating and preventing ischemia-related injuries in subjects.
Career Highlights
Throughout her career, Lina Badimon Maestro has worked with reputable institutions, including the Consejo Superior De Investigaciones Cientificas and the Fundació Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau. Her work has been pivotal in advancing understanding and treatment of ischemic conditions, positioning her as a leading figure in medical research.
Collaborations
Lina's success is attributed in part to her collaborations with esteemed colleagues such as Judit Cubedo Ràfols and Teresa Padró Capmany. Together, they have contributed to innovative solutions in the realm of ischemia, enhancing the collective knowledge and research outcomes in this critical area.
Conclusion
Lina Badimon Maestro's dedication to advancing ischemia research through her patented inventions exemplifies the impact that innovative thinkers can have in the medical field. Her ongoing commitment to improving patient outcomes signifies her essential role in shaping the future of ischemia diagnosis and treatment. Through her work, Lina continues to inspire the next generation of inventors and researchers striving to make a difference in healthcare.